[Therapy of primary hyperlipemia].
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001796:Blood Protein Disorders / Q000628:therapy; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D004038:Diet, Reducing; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D006949:Hyperlipidemias / Q000145:classification / Q000188:drug therapy* / Q000235:genetics / Q000628:therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D009539:Nicotinic Acids / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D000960:Hypolipidemic Agents; D008055:Lipids; D008074:Lipoproteins; D009539:Nicotinic Acids; D002792:Cholestyramine Resin; D002994:Clofibrate
Therapie der primären Hyperlipidämien.